Halozyme Therapeutics Inc (HALO) — Financial Flexibility Index
Halozyme Therapeutics Inc (HALO) has a Financial Flexibility Index of 0.11x as of September 2025. Free cash flow of $181.63 Million (operating CF $178.60 Million minus capex $3.03 Million) represents 0% of total liabilities ($1.72 Billion). Check Halozyme Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Halozyme Therapeutics Inc Financial Flexibility Index (2001–2024)
Historical Financial Flexibility Index trend for Halozyme Therapeutics Inc across 24 annual periods. For the full cash flow conversion analysis, see Halozyme Therapeutics Inc cash flow conversion.
Annual Financial Flexibility Index for Halozyme Therapeutics Inc (2001–2024)
Year-by-year free cash flow to debt coverage for Halozyme Therapeutics Inc. Explore how well can Halozyme Therapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.29x | $489.76 Million | $479.06 Million | $1.70 Billion | ▲ +17.7% |
| 2023 | 0.24x | $403.87 Million | $388.57 Million | $1.65 Billion | ▲ +67.1% |
| 2022 | 0.15x | $244.92 Million | $240.11 Million | $1.67 Billion | ▼ -55.8% |
| 2021 | 0.33x | $300.90 Million | $299.44 Million | $907.48 Million | ▲ +145.4% |
| 2020 | 0.14x | $57.96 Million | $55.45 Million | $428.88 Million | ▲ +178.7% |
| 2019 | -0.17x | $-81.38 Million | $-85.42 Million | $474.11 Million | ▲ +26.7% |
| 2018 | -0.23x | $-44.84 Million | $-49.50 Million | $191.36 Million | ▼ -153.9% |
| 2017 | 0.43x | $135.40 Million | $134.05 Million | $311.58 Million | ▲ +370.4% |
| 2016 | -0.16x | $-47.25 Million | $-50.38 Million | $294.00 Million | ▲ +35.8% |
| 2015 | -0.25x | $-34.72 Million | $-37.08 Million | $138.79 Million | ▲ +32.4% |
| 2014 | -0.37x | $-46.15 Million | $-47.52 Million | $124.62 Million | ▲ +4.1% |
| 2013 | -0.39x | $-47.04 Million | $-49.34 Million | $121.78 Million | ▲ +47.3% |
| 2012 | -0.73x | $-62.92 Million | $-64.33 Million | $85.87 Million | ▼ -19.9% |
| 2011 | -0.61x | $-33.52 Million | $-34.35 Million | $54.86 Million | ▲ +3.0% |
| 2010 | -0.63x | $-44.74 Million | $-45.39 Million | $70.99 Million | ▼ -14.4% |
| 2009 | -0.55x | $-38.69 Million | $-40.15 Million | $70.25 Million | ▲ +1.5% |
| 2008 | -0.56x | $-34.21 Million | $-35.37 Million | $61.18 Million | ▼ -1252.2% |
| 2007 | 0.05x | $2.22 Million | $-147.66K | $45.69 Million | ▼ -85.0% |
| 2006 | 0.32x | $7.44 Million | $7.08 Million | $23.01 Million | ▲ +105.9% |
| 2005 | -5.49x | $-12.65 Million | $-13.00 Million | $2.30 Million | ▼ -15.8% |
| 2004 | -4.74x | $-7.49 Million | $-7.72 Million | $1.58 Million | ▼ -257.1% |
| 2003 | -1.33x | $-49.73K | $-49.73K | $37.45K | ▲ +75.2% |
| 2002 | -5.35x | $-55.78K | $-55.78K | $10.43K | ▲ +48.8% |
| 2001 | -10.45x | $-34.37K | $-34.37K | $3.29K | — |